PENNELLI, GIANMARIA
 Distribuzione geografica
Continente #
NA - Nord America 14.877
AS - Asia 8.759
EU - Europa 4.178
SA - Sud America 1.314
AF - Africa 1.239
Continente sconosciuto - Info sul continente non disponibili 214
OC - Oceania 136
Totale 30.717
Nazione #
US - Stati Uniti d'America 14.111
SG - Singapore 2.426
CN - Cina 1.727
VN - Vietnam 1.471
IT - Italia 1.005
BR - Brasile 815
HK - Hong Kong 807
BD - Bangladesh 555
DE - Germania 394
SE - Svezia 347
FR - Francia 298
FI - Finlandia 266
IN - India 246
NL - Olanda 199
GB - Regno Unito 190
RU - Federazione Russa 190
PL - Polonia 158
CA - Canada 150
UA - Ucraina 130
IQ - Iraq 122
BJ - Benin 120
JP - Giappone 115
AR - Argentina 107
TR - Turchia 104
KR - Corea 98
MX - Messico 88
PH - Filippine 83
IE - Irlanda 78
ZA - Sudafrica 77
ID - Indonesia 72
PK - Pakistan 67
ES - Italia 65
CO - Colombia 63
EC - Ecuador 61
VE - Venezuela 60
AT - Austria 57
JM - Giamaica 56
MA - Marocco 56
CR - Costa Rica 52
GR - Grecia 52
EG - Egitto 51
CL - Cile 49
SA - Arabia Saudita 49
AU - Australia 48
UZ - Uzbekistan 48
CI - Costa d'Avorio 46
RO - Romania 46
AE - Emirati Arabi Uniti 45
DO - Repubblica Dominicana 45
AL - Albania 43
TN - Tunisia 43
MY - Malesia 42
KE - Kenya 40
PY - Paraguay 40
IR - Iran 39
PE - Perù 39
JO - Giordania 38
LA - Repubblica Popolare Democratica del Laos 38
EE - Estonia 37
GT - Guatemala 37
AZ - Azerbaigian 36
BG - Bulgaria 36
CY - Cipro 36
NP - Nepal 35
TH - Thailandia 35
UY - Uruguay 35
AM - Armenia 34
CZ - Repubblica Ceca 34
HN - Honduras 34
PS - Palestinian Territory 34
BZ - Belize 33
DZ - Algeria 33
HR - Croazia 33
IL - Israele 33
KZ - Kazakistan 33
MK - Macedonia 33
SN - Senegal 33
BE - Belgio 32
BY - Bielorussia 32
LC - Santa Lucia 32
BA - Bosnia-Erzegovina 31
DK - Danimarca 31
LV - Lettonia 31
MU - Mauritius 31
BF - Burkina Faso 30
CH - Svizzera 30
LB - Libano 30
NZ - Nuova Zelanda 30
PT - Portogallo 30
RS - Serbia 30
ET - Etiopia 29
GA - Gabon 29
LU - Lussemburgo 29
MN - Mongolia 29
PR - Porto Rico 29
SI - Slovenia 29
CW - ???statistics.table.value.countryCode.CW??? 28
KH - Cambogia 28
NO - Norvegia 28
PA - Panama 28
Totale 29.267
Città #
Ashburn 1.925
Fairfield 1.565
Singapore 1.521
San Jose 1.297
Woodbridge 885
Hong Kong 724
Chandler 723
Houston 700
Cambridge 606
Seattle 570
Wilmington 554
Ann Arbor 515
Ho Chi Minh City 425
Beijing 418
Jacksonville 317
Hanoi 308
Los Angeles 291
Santa Clara 291
Boardman 249
New York 172
Princeton 163
Padova 159
San Diego 145
Helsinki 136
Hefei 133
Council Bluffs 120
Cotonou 119
Lauterbourg 119
Dong Ket 100
São Paulo 91
Medford 88
Buffalo 87
Munich 86
Da Nang 84
Milan 79
Nanjing 78
Seoul 77
Bytom 75
Des Moines 73
Tokyo 73
The Dalles 69
Rome 67
Chicago 64
Dublin 63
Guangzhou 58
Roxbury 57
Warsaw 57
Baghdad 52
Nuremberg 52
Dallas 51
Haiphong 51
Amsterdam 49
Columbus 46
Abidjan 45
London 45
Orem 45
San José 41
Tashkent 41
Chennai 37
Amman 35
Baku 34
Kingston 34
Montreal 34
Vientiane 34
Dakar 33
Frankfurt am Main 33
Nairobi 33
Shanghai 33
Atlanta 31
Brooklyn 31
Castries 30
Johannesburg 30
Montevideo 30
Toronto 30
Turku 30
Vienna 30
Padua 29
Ulan Bator 29
Hải Dương 28
Tianjin 28
Denver 27
Kampala 27
Libreville 27
Nanchang 27
Naples 27
Phoenix 27
Rio de Janeiro 27
Tirana 27
Yerevan 27
Lima 26
Mexico City 26
Panama City 26
Paris 26
Phnom Penh 26
Stockholm 26
Willemstad 26
Conakry 25
Harare 25
Ouagadougou 25
Poplar 25
Totale 18.315
Nome #
0C22 men2A da mutazione di ret C6009S. descrizione di una grande famiglia 610
F-actin dynamics regulates mammalian organ growth and cell fate maintenance 457
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors 420
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 405
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 392
Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism 378
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 366
Autoimmune gastritis: histology phenotype and OLGA staging. 342
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 340
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma 338
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 336
Minimally invasive enucleation of esophageal leiomyoma 326
A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation 313
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 307
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 307
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 304
A registry-based study of thyroid paraganglioma: histological and genetic characteristics. 300
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 298
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 298
Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics 295
FDG-PET/ct and parathyroid carcinoma. Review of literature and illustrative case series 292
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 290
Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer 289
An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature 284
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 274
PD-L1 expression in gastroesophageal dysplastic lesions 274
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 273
The role of the size in thyroid cancer risk stratification 273
Predictors of neoplastic progression in gastroesophageal lesions indefinite for dysplasia 270
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs 268
Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. 267
Galectin-3 cytotest in thyroid follicular neoplasia: a prospective,monoinstitutional study 265
Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery. 265
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor 265
Polydatin prevents calcium pyrophosphate crystal-induced arthritis in mice 250
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 250
Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients 248
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 248
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 247
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 247
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience 246
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 245
Gastritis: update on etiological features and histological practical approach 245
Histopathological landscape of rare oesophageal neoplasms 244
Estrogen and thyroid cancer is a stem affair: A preliminary study 243
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 243
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 243
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 243
Gastritis staging in clinical practice: the OLGA staging system 240
Atrophic gastritis: pathology and endoscopy in the reversibility assessment. 240
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 238
Medullary Thyroid Carcinoma in a Patient with MEN 1 Syndrome. Case Report and Literature Review 237
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131 I uptake 236
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 235
Programmed cell death 4 protein in esophageal cancer 234
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma 234
Periodontal Injection of Lipopolysaccharide Promotes Arthritis Development in Mice 233
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 233
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application 229
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 227
Effect of intra-articular injection of a hyaluronic acid-alendronate conjugate on post-traumatic osteoarthritis induced by destabilization of the medial meniscus in rats 224
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study 224
Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial 223
Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia 223
Barrett's epithelium after antireflux surgery 221
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 220
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience 219
The pathologic and molecular landscape of esophageal squamous cell carcinogenesis 218
A practical approach for PD-L1 evaluation in gastroesophageal cancer 215
Solitary fibrous tumour of the thyroid gland: a report of two cases with an analysis of their clinical and pathological features. 213
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 213
Bactericidal/Permeability-Increasing Protein Downregulates the Inflammatory Response in In Vivo Models of Arthritis 212
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes 211
BRAF nei carcinomi tiroidei primitivi e nelle loro recidive: correlazione con la capacità di concentrare lo iodio e il 18-FDG 210
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 208
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 207
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations 207
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 206
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 205
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 205
Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma 204
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 203
The rising incidence of papillary thyroid cancer: More cancers or more assessments? 203
Can we avoid inadvertend parathyroidectomy during thyroid surgery? 201
Gastritis: the histology report. 200
Clear cell dysplasia in a sessile serrated adenoma 200
Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia 199
Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. 199
Barrett's epithelium after antireflux surgery 199
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 199
Relationship between pathologic T-Stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer 198
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 198
Glucose metabolism in prymary and metastatic thyroid cancers 190
Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization. 186
Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions 185
PDCD4 expression in thyroid neoplasia 184
LPS-INDUCED PERIODONTITIS PROMOTES ARTHRITIS DEVELOPMENT IN MICE 180
Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy. 177
Braf mutations in primary and metastatic thyroid tumors 176
OLGA Gastrits staging in young adults and country-specific Gastric Cancer Risk 175
Totale 25.379
Categoria #
all - tutte 86.535
article - articoli 79.971
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.144
Totale 167.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.803 0 158 206 149 151 158 95 200 86 70 175 355
2022/20231.412 256 181 27 185 205 196 6 81 158 21 83 13
2023/2024865 36 98 111 63 92 90 103 54 45 25 75 73
2024/20253.428 25 181 174 127 391 151 151 313 300 141 580 894
2025/202615.855 770 1.381 1.728 2.272 1.296 700 2.392 1.234 1.527 873 759 923
2026/2027844 673 171 0 0 0 0 0 0 0 0 0 0
Totale 30.717